The insomnia phenotype in genetic Creutzfeldt–Jakob disease based on the E200K mutation

References

• Masters CL, Harris JO, Gajdusek DC, et al. Creutzfeldt-Jakob disease: patterns of world wide occurrence significance of familial and sporadic clustering. Ann Neurol. 1979;5:117–188.
   Web of Science ®Google Scholar
• Kovacs GG, Puopolo M, Ladogana A, et al. Genetic prion disease: the EUROCJD experience. Hum Genet. 2005;18:166–174.
   Google Scholar
• Ladogana A, Puopolo M, Croes EA, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005;64(9):1586–1591.
   PubMed Web of Science ®Google Scholar
• Minikel EV, Vallabh SM, Lek M, et al. Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med. 2016;8(322):322ra9.
   PubMed Web of Science ®Google Scholar
• Cohen OS, Kimiagar I, Korczyn AD, et al. Unusual presentations in patients with E200K familial Creutzfeldt-Jakob disease. Eur J Neurol. 2016;23(5):871–877.
   PubMed Web of Science ®Google Scholar
• Geevasinga N, Simon NG, Collins S, et al. Sporadic Creutzfeldt-Jakob disease presenting as spastic paraparesis. Eur J Neurol. 2013;20(5):e73–4.
   PubMed Web of Science ®Google Scholar
• Parchi P, Petersen RB, Chen SG, et al. Molecular pathology of fatal familial insomnia. Brain Pathol. 1998;8(3):539–548.
   PubMed Web of Science ®Google Scholar
• Mitrova E, Wsolova L, Janakova A. [Riziko horizontálneho šírenia Creutzfeldtovej_Jakobovej choroby z pohľadu novších poznatkov.]. Neurol Prax. 2007;3:144–146.
   Google Scholar
• Kang P, De Bruin GS, Wang LH, et al. Sleep pathology in Creutzfeldt-Jakob disease. J Clin Sleep Med. 2016;12(7):1033–1039.
   PubMed Web of Science ®Google Scholar
• Wall CA, Rummans TA, Aksamit AJ, et al. Psychiatric manifestations of Creutzfeldt-Jakob disease: a 25-year analysis. J Neuropsychiatry Clin Neurosci. 2005;17(4):489–495.
   PubMed Web of Science ®Google Scholar
• Chapman J, Arlazoroff A, Goldfarb LG, et al. Fatal insomnia in a case of familial Creutzfeldt-Jakob disease with the codon 200 (Lys) mutation. Neurology. 1996;46:758–761.
   PubMed Web of Science ®Google Scholar
• Taratuto AL, Piccardo P, Reich EG, et al. Insomnia associated with thalamic involvement in E200K Creutzfeldt-Jakob disease. Neurology. 2002;58(3):362–367.
   PubMed Web of Science ®Google Scholar
• Parchi P, Strammiello R, Giese A, et al. Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future. Acta Neuropathol. 2011;121:91.
   PubMed Web of Science ®Google Scholar
• Gmitterova K, Heinemann U, Krasnianski A, et al. Cerebrospinal fluid markers in the differentiation of molecular subtypes of sporadic Creutzfeldt−Jakob disease. Eur J Neurol. 2016;23(6):1126–1133.
   PubMed Web of Science ®Google Scholar
• Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology. 2004;63:443–449.
   PubMed Web of Science ®Google Scholar
• Demaerel P, Heiner L, Robberecht W, et al. Diffusion-weighted MRI in sporadic Creutzfeldt–Jakob disease. Neurology. 1999;52:205–208.
   PubMed Web of Science ®Google Scholar
• Urbach H, Klisch J, Wolf HK, et al. MRI in sporadic Creutzfeldt-Jakob disease: correlation with clinical and neuropathological data. Neuroradiology. 1998;40:65–70.
   PubMed Web of Science ®Google Scholar
• Meissner B, Kallenberg K, Sanchez-Juan P, et al. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology. 2009;72:1994–2001.
   PubMed Web of Science ®Google Scholar
• Oppenheim C, Zuber M, Galanaud D, et al. Spectroscopy and serial diffusion MR findings in hGH-Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 2004;75(7):1066–1069.
   PubMed Web of Science ®Google Scholar
• Krasnianski A, Heinemann U, Ponto C, et al. Clinical findings and diagnosis in genetic prion diseases in Germany. Eur J Epidemiol. 2016;31(2):187–196.
   PubMed Web of Science ®Google Scholar
• Cohen OS, Chapman J, Korczyn AD, et al. Familial Creutzfeldt-Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD. J Neurol. 2015;262(3):604–613.
   PubMed Web of Science ®Google Scholar
• Lee H, Rosenmann H, Chapman J, et al. Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers. Brain. 2009;132:2680–2687.
   PubMed Web of Science ®Google Scholar
• Grau-Rivera O, Calvo A, Bargalló N, et al. Quantitative magnetic resonance abnormalities in Creutzfeldt-Jakob disease and fatal Insomnia. J Alzheimers Dis. 2017;55(1):431–443.
   PubMed Web of Science ®Google Scholar
• Tschampa HJ, Herms JW, Schulz-Schaeffer WJ, et al. Clinical findings in sporadic Creutzfeldt–jakob disease correlate with thalamic pathology. Brain. 2002;125:2558–2566.
   PubMed Web of Science ®Google Scholar
• Jung KY, Seo DW, Na DL, et al. Source localization of periodic sharp wave complexes using independent component analysis in sporadic Creutzfeldt-Jakob disease. Brain Res. 2007;1143:228–237.
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Seguin J, Quadrio I. Genetic Creutzfeldt–Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy. Acta Neuropathol. 2011;121:39–57.
   PubMed Web of Science ®Google Scholar
• Korczyn AD. Creutzfeldt–Jakob disease among libyan jews. Eur J Epidemiol. 1991;7:490–493.
   PubMed Web of Science ®Google Scholar
• Moody KM, Schonberger LB, Maddox RA, et al. Sporadic fatal insomnia in a young woman: a diagnostic challenge: case report. BMC Neurol. 2011;11:136.
   PubMed Web of Science ®Google Scholar
• Wu L, Lu H, Wang X, et al. Clinical features and sleep analysis of Chinese patients with fatal familial Insomnia. Sci Rep. 2017;7(1):3625.
   PubMedGoogle Scholar